eye complications case presentation
play

eye complications: case presentation Nicholas J A Webb Royal - PowerPoint PPT Presentation

A girl with cystinosis with bone and eye complications: case presentation Nicholas J A Webb Royal Manchester Childrens Hospital Manchester, UK Raptor Symposium ESPN meeting, Porto September 2014 Case history Born 29 10 2005 BW 4.3kg


  1. A girl with cystinosis with bone and eye complications: case presentation Nicholas J A Webb Royal Manchester Children’s Hospital Manchester, UK Raptor Symposium ESPN meeting, Porto September 2014

  2. Case history • Born 29 10 2005 BW 4.3kg • Parents first cousins. Pakistani migrants to UK. • Presentation Nov 2006 at 13 months of age – Polyuria and polydipsia, diarrhoea and failure to thrive from 9 months of age – Previous rickets – Vitamin D deficient and treated – Acute illness with metabolic decompensation and impaired renal function. – Renal glycosuria with Fanconi syndrom • Diagnosis – WBC cystine 3.8nmol½cystine/mg protein – Eye exam – bilateral peripheral corneal opacities – Homozygous for c.18_21delGACT mutation in exon 3 of CTNS – Also found to have right duplex kidney with non-functioning upper moiety. Radiological evidence of bilateral renal dysplasia

  3. Case history • Commenced treatment – Mercaptamine bitartrate – Cysteamine eye drops – Phosphate Sandoz – Potassium citrate – One alphahydroxycholecalciferol – Indometacin – Omperazole – Sodium bicarbonate – Erythropoietin • Discharged home with stable biochemistry – Plasma creatinine 43µmol/l

  4. Case history • Poor adherence with all prescribed therapy • Poor WBC cystine control • Continuous photophobia • Minor electrolyte abnormalities • However adequate PTH control and no radiological evidence bone disease • Progressive deterioration in renal function – Rise in plasma creatinine from 2 years of age – Listed for transplantation July 2013 • Pre-emptive deceased donor transplant Nov 2013 – 46y male. Subarachnoid haemorrhage. 1:1:0 mismatch. CMV D-/R- – TWIST immunosuppressive regimen – basiliximab x2, tacrolimus, MMF with corticosteroid withdrawal at D4. – Good primary transplant function – No early complications – discharged home D13 – plasma creatinine 53µmol/l

  5. Ongoing eye problems • Very poor adherence with cysteamine eye drops • Significant photophobia • Progressive onset of persistent irritation, itching and watering of the eyes • Ophthalmology review revealed the development of corneal epithelial erosions • Lubricant eye drops prescribed

  6. Bone problems • Onset of left knee pain December 2013 • Progressive worsening with difficulty weight bearing • Development of pain in right knee and left hip • Orthopaedic review – Fixed flexion deformities of left hip (20 o ) and left knee (30 o ) – Decreased range of movement

  7. Knee X-ray Changes consistent with avascular necrosis in left lateral femoral condyle and right medial femoral condyle. Significant chronicity of changes.

  8. Hip X-ray Changes consistent with avascular necrosis of both femoral heads, L>R

  9. Hip MR coronal T2 High signal in left femoral head consistent with changes secondary to avascular necrosis. Other views show similar, less severe changes in right hip.

  10. Treatment and progress • Physiotherapy initially counter-productive • Required escalating doses of analgesia • Became wheelchair dependent • Surgery April 2014 – Bilateral knee arthroscopy – Extensive abnormality with degeneration of articular cartilage – removed – Microfracture performed using K-wire – Infusion of local anaesthetic • Significant improvement in symptoms – More mobile, analgesia free • Kidney function remains stable

  11. Summary and introduction of expert speakers • Significant ocular and orthopaedic symptoms both presenting following kidney transplantation • Wide differential diagnosis in the patient with cystinosis, particularly with increasing age • Introduction of expert speakers – Dr Martine Besouw – Mr Sus Biswas

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend